Drug information for EMTRICITABINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 200MG Tentative Approval   EMTRICITABINE emtricitabine AUROBINDO PHARMA 79188
2008-12-19 Letter
CAPSULE; ORAL 200MG Tentative Approval   EMTRICITABINE emtricitabine MATRIX LABS LTD 90488
2009-01-02 Letter
CAPSULE; ORAL 200MG Tentative Approval   EMTRICITABINE emtricitabine CIPLA LIMITED 91168
2011-04-01 Letter

Drug Adverse Effects information for EMTRICITABINE

Role code Indications Reaction # Reports
SS ANTIRETROVIRAL THERAPY DRUG RESISTANCE 15
SS ANTIRETROVIRAL THERAPY PSYCHIATRIC SYMPTOM 15
SS ANTIVIRAL TREATMENT HEPATITIS C 5
SS CYTOMEGALOVIRUS CHORIORETINITIS BLOOD ALKALINE PHOSPHATASE INCREASED 2
SS CYTOMEGALOVIRUS CHORIORETINITIS BRONCHOPULMONARY ASPERGILLOSIS 2
SS CYTOMEGALOVIRUS CHORIORETINITIS CYTOMEGALOVIRUS CHORIORETINITIS 2
SS CYTOMEGALOVIRUS CHORIORETINITIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
SS CYTOMEGALOVIRUS CHORIORETINITIS LYMPHOMA 2
SS CYTOMEGALOVIRUS CHORIORETINITIS PLATELET COUNT DECREASED 2
SS HIV INFECTION ABSCESS NECK 3
SS HIV INFECTION ARTHRALGIA 6
SS HIV INFECTION ARTHRITIS 6
SS HIV INFECTION BLOOD ALKALINE PHOSPHATASE INCREASED 12
SS HIV INFECTION BLOOD THYROID STIMULATING HORMONE INCREASED 6
SS HIV INFECTION BRONCHOPULMONARY ASPERGILLOSIS 12
SS HIV INFECTION CD4 LYMPHOCYTES INCREASED 17
SS HIV INFECTION CEREBRAL TOXOPLASMOSIS 17
SS HIV INFECTION CRYOGLOBULINS PRESENT 6
SS HIV INFECTION CYTOMEGALOVIRUS CHORIORETINITIS 12
SS HIV INFECTION DEMENTIA 4
SS HIV INFECTION DIARRHOEA 20
SS HIV INFECTION DRUG RESISTANCE 17
SS HIV INFECTION DYSPHONIA 6
SS HIV INFECTION EAR INFECTION 17
SS HIV INFECTION EPILEPSY 17
SS HIV INFECTION FEBRILE CONVULSION 3
SS HIV INFECTION GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
SS HIV INFECTION GASTROINTESTINAL DISORDER 17
SS HIV INFECTION GENERALISED OEDEMA 6
SS HIV INFECTION HEPATOTOXICITY 17
SS HIV INFECTION HYPERTHYROIDISM 6
SS HIV INFECTION HYPOTHYROIDISM 6
SS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 26
SS HIV INFECTION KLEBSIELLA INFECTION 3
SS HIV INFECTION LETHARGY 6
SS HIV INFECTION LYMPHADENITIS BACTERIAL 3
SS HIV INFECTION LYMPHOMA 12
SS HIV INFECTION MENINGITIS 17
SS HIV INFECTION MONOPLEGIA 17
SS HIV INFECTION NAUSEA 17
SS HIV INFECTION NEOPLASM MALIGNANT 6
SS HIV INFECTION OESOPHAGEAL CANDIDIASIS 17
SS HIV INFECTION PLATELET COUNT DECREASED 12
SS HIV INFECTION PNEUMONIA STREPTOCOCCAL 17
SS HIV INFECTION POLYNEUROPATHY 17
SS HIV INFECTION PORTAL HYPERTENSION 33
SS HIV INFECTION PULMONARY ARTERIAL HYPERTENSION 8
SS HIV INFECTION QUADRIPARESIS 17
SS HIV INFECTION RENAL FAILURE ACUTE 3
SS HIV INFECTION RHABDOMYOLYSIS 3
SS HIV INFECTION RHEUMATOID ARTHRITIS 6
SS HIV INFECTION RHEUMATOID FACTOR INCREASED 6
SS HIV INFECTION SEPSIS 17
SS HIV INFECTION SQUAMOUS CELL CARCINOMA OF SKIN 6
SS HIV INFECTION SYNOVITIS 6
SS HIV INFECTION TREATMENT FAILURE 17
SS HIV INFECTION TREATMENT NONCOMPLIANCE 17
SS HIV INFECTION VIITH NERVE PARALYSIS 17
SS HIV INFECTION VIRAL LOAD INCREASED 17
SS HIV INFECTION VIRAL UPPER RESPIRATORY TRACT INFECTION 3
SS HIV INFECTION VOMITING 17
SS HIV INFECTION WEIGHT INCREASED 6
SS HIV INFECTION WOUND 6
SS OPPORTUNISTIC INFECTION PROPHYLAXIS BLOOD ALKALINE PHOSPHATASE INCREASED 2
SS OPPORTUNISTIC INFECTION PROPHYLAXIS BRONCHOPULMONARY ASPERGILLOSIS 2
SS OPPORTUNISTIC INFECTION PROPHYLAXIS CYTOMEGALOVIRUS CHORIORETINITIS 2
SS OPPORTUNISTIC INFECTION PROPHYLAXIS GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
SS OPPORTUNISTIC INFECTION PROPHYLAXIS LYMPHOMA 2
SS OPPORTUNISTIC INFECTION PROPHYLAXIS PLATELET COUNT DECREASED 2
SS PNEUMONIA STREPTOCOCCAL CD4 LYMPHOCYTES INCREASED 1
SS PNEUMONIA STREPTOCOCCAL CEREBRAL TOXOPLASMOSIS 1
SS PNEUMONIA STREPTOCOCCAL DIARRHOEA 1
SS PNEUMONIA STREPTOCOCCAL DRUG RESISTANCE 1
SS PNEUMONIA STREPTOCOCCAL EAR INFECTION 1
SS PNEUMONIA STREPTOCOCCAL EPILEPSY 1
SS PNEUMONIA STREPTOCOCCAL GASTROINTESTINAL DISORDER 1
SS PNEUMONIA STREPTOCOCCAL HEPATOTOXICITY 1
SS PNEUMONIA STREPTOCOCCAL IMMUNE RECONSTITUTION SYNDROME 1
SS PNEUMONIA STREPTOCOCCAL MENINGITIS 1
SS PNEUMONIA STREPTOCOCCAL MONOPLEGIA 1
SS PNEUMONIA STREPTOCOCCAL NAUSEA 1
SS PNEUMONIA STREPTOCOCCAL OESOPHAGEAL CANDIDIASIS 1
SS PNEUMONIA STREPTOCOCCAL PNEUMONIA STREPTOCOCCAL 1
SS PNEUMONIA STREPTOCOCCAL POLYNEUROPATHY 1
SS PNEUMONIA STREPTOCOCCAL QUADRIPARESIS 1
SS PNEUMONIA STREPTOCOCCAL SEPSIS 1
SS PNEUMONIA STREPTOCOCCAL TREATMENT FAILURE 1
SS PNEUMONIA STREPTOCOCCAL TREATMENT NONCOMPLIANCE 1
SS PNEUMONIA STREPTOCOCCAL VIITH NERVE PARALYSIS 1
SS PNEUMONIA STREPTOCOCCAL VIRAL LOAD INCREASED 1
SS PNEUMONIA STREPTOCOCCAL VOMITING 1
SS PRODUCT USED FOR UNKNOWN INDICATION DIARRHOEA 1
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 1
SS PRODUCT USED FOR UNKNOWN INDICATION RHABDOMYOLYSIS 1
C ANTIBIOTIC PROPHYLAXIS DIALYSIS 2
C ANTIBIOTIC PROPHYLAXIS RENAL FAILURE 6
C ANTIFUNGAL PROPHYLAXIS DIALYSIS 1
C ANTIFUNGAL PROPHYLAXIS RENAL FAILURE 3
C ANTIRETROVIRAL THERAPY BACTERIAL SEPSIS 4
C ANTIRETROVIRAL THERAPY NEUTROPENIA 4
C ANTIVIRAL PROPHYLAXIS BURKITT'S LYMPHOMA 3
C ANTIVIRAL PROPHYLAXIS CEREBRAL TOXOPLASMOSIS 3
C ANTIVIRAL PROPHYLAXIS NEOPLASM RECURRENCE 3
C ANTIVIRAL PROPHYLAXIS OFF LABEL USE 3
C ANTIVIRAL PROPHYLAXIS URINARY RETENTION 3
C ANTIVIRAL TREATMENT RENAL TUBULAR ACIDOSIS 4
C BURKITT'S LYMPHOMA BURKITT'S LYMPHOMA 11
C BURKITT'S LYMPHOMA CEREBRAL TOXOPLASMOSIS 11
C BURKITT'S LYMPHOMA NEOPLASM RECURRENCE 11
C BURKITT'S LYMPHOMA OFF LABEL USE 11
C BURKITT'S LYMPHOMA URINARY RETENTION 11
C FEBRILE NEUTROPENIA BACTERIAL SEPSIS 6
C FEBRILE NEUTROPENIA NEUTROPENIA 6
C HEPATITIS C HYPERBILIRUBINAEMIA 24
C HEPATITIS C RENAL FAILURE 24
C HIV INFECTION ACIDOSIS 3
C HIV INFECTION BASAL CELL CARCINOMA 2
C HIV INFECTION BLOOD CREATININE INCREASED 7
C HIV INFECTION CIRCULATORY COLLAPSE 9
C HIV INFECTION COMA 9
C HIV INFECTION CONGENITAL ANOMALY 1
C HIV INFECTION DIALYSIS 3
C HIV INFECTION DISTRIBUTIVE SHOCK 3
C HIV INFECTION DRUG INTERACTION 10
C HIV INFECTION DRUG LEVEL INCREASED 7
C HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 1
C HIV INFECTION HEART RATE INCREASED 3
C HIV INFECTION HYPERBILIRUBINAEMIA 32
C HIV INFECTION INTERNATIONAL NORMALISED RATIO DECREASED 3
C HIV INFECTION METABOLIC ACIDOSIS 6
C HIV INFECTION OVERDOSE 9
C HIV INFECTION POLYDACTYLY 1
C HIV INFECTION POLYURIA 3
C HIV INFECTION RENAL FAILURE 48
C HIV INFECTION RENAL IMPAIRMENT 7
C HIV INFECTION SHOCK 6
C HYPERTENSION BLOOD CREATININE INCREASED 3
C HYPERTENSION DRUG INTERACTION 3
C HYPERTENSION DRUG LEVEL INCREASED 3
C HYPERTENSION RENAL IMPAIRMENT 3
C LIPIDS INCREASED BLOOD CREATININE INCREASED 1
C LIPIDS INCREASED DRUG INTERACTION 1
C LIPIDS INCREASED DRUG LEVEL INCREASED 1
C LIPIDS INCREASED RENAL IMPAIRMENT 1
C MEAN ARTERIAL PRESSURE CIRCULATORY COLLAPSE 5
C MEAN ARTERIAL PRESSURE COMA 5
C MEAN ARTERIAL PRESSURE DISTRIBUTIVE SHOCK 5
C MEAN ARTERIAL PRESSURE METABOLIC ACIDOSIS 5
C MEAN ARTERIAL PRESSURE OVERDOSE 5
C MEAN ARTERIAL PRESSURE RENAL FAILURE 5
C MIGRAINE BLOOD CREATININE INCREASED 2
C MIGRAINE DRUG INTERACTION 2
C MIGRAINE DRUG LEVEL INCREASED 2
C MIGRAINE RENAL IMPAIRMENT 2
C MYALGIA HYPERBILIRUBINAEMIA 8
C MYALGIA RENAL FAILURE 8
C NON-HODGKIN'S LYMPHOMA STAGE IV BACTERIAL SEPSIS 9
C NON-HODGKIN'S LYMPHOMA STAGE IV NEUTROPENIA 9
C OVERDOSE ACIDOSIS 1
C OVERDOSE CIRCULATORY COLLAPSE 1
C OVERDOSE COMA 1
C OVERDOSE OVERDOSE 1
C OVERDOSE RENAL FAILURE 1
C OVERDOSE SHOCK 1
C PRODUCT USED FOR UNKNOWN INDICATION BACTERIAL SEPSIS 1
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD ALCOHOL INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD CREATININE INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION CIRCULATORY COLLAPSE 6
C PRODUCT USED FOR UNKNOWN INDICATION COMA 6
C PRODUCT USED FOR UNKNOWN INDICATION DISTRIBUTIVE SHOCK 1
C PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 2
C PRODUCT USED FOR UNKNOWN INDICATION DRUG LEVEL INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION HEART RATE INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION METABOLIC ACIDOSIS 6
C PRODUCT USED FOR UNKNOWN INDICATION NEUTROPENIA 1
C PRODUCT USED FOR UNKNOWN INDICATION OVERDOSE 4
C PRODUCT USED FOR UNKNOWN INDICATION POLYURIA 5
C PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE 8
C PRODUCT USED FOR UNKNOWN INDICATION RENAL IMPAIRMENT 2
C PRODUCT USED FOR UNKNOWN INDICATION SHOCK 4
C TAKAYASU'S ARTERITIS DRUG INTERACTION 1
C TAKAYASU'S ARTERITIS INTERNATIONAL NORMALISED RATIO DECREASED 1
C VITAMIN SUPPLEMENTATION DIALYSIS 1
C VITAMIN SUPPLEMENTATION RENAL FAILURE 3
I CONTRACEPTION DRUG INEFFECTIVE 2
I CONTRACEPTION DRUG INTERACTION 2
I CONTRACEPTION ECTOPIC PREGNANCY 2
I HIV INFECTION DRUG INEFFECTIVE 10
I HIV INFECTION DRUG INTERACTION 10
I HIV INFECTION ECTOPIC PREGNANCY 10
Ads by Google